NK VUE
Live / Registered — Registered — Sections 8 & 15 accepted and acknowledged (as of 04 Feb 2023)
What this means for you
Registered since 05 Jul 2016. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 86300720
- Registration number
- 4993881
- Mark type
- Stylized text
- Filed
- 04 Jun 2014
- Published for opposition
- 18 Aug 2015
- Registered
- 05 Jul 2016
- Attorney of record
- Deborah L. Corpus
Goods and services
- Class 001 — Chemicals: NK cell activation testing kits containing peptide substrates used in analyzing and detecting certain toxins for clinical, research or medical laboratory use; diagnostic kits for clinical laboratory use, namely, kits consisting primarily of monoclonal antibodies and/or recombinant proteins, RNA, DNA for use in disease diagnosis, screening, monitoring, prognosis, and immune status; diagnostic kits for medical laboratory use, namely, kits consisting primarily of monoclonal antibodies and/or recombinant proteins, RNA, DNA for use in disease diagnosis, screening, monitoring, prognosis, and immune status; diagnostic kits for medical research use, namely, kits consisting primarily of (monoclonal antibodies and/or recombinant proteins, RNA, DNA for use in disease diagnosis, screening, monitoring, prognosis, and immune status; diagnostic kits for clinical research use, namely, kits consisting primarily of monoclonal antibodies and/or recombinant proteins, RNA, DNA for use in disease diagnosis, screening, monitoring, prognosis, and immune status; diagnostic preparations for clinical laboratory use and medical laboratory use; diagnostic preparations for clinical research use other than for medical use; diagnostic reagents for clinical laboratory use, medical laboratory use, medical research use and clinical research use
- Class 005 — Pharmaceuticals: diagnostic kits for medical diagnostic use, namely, kits consisting primarily of monoclonal antibodies and/or recombinant proteins, RNA, DNA for use in disease diagnosis, screening, monitoring, prognosis, and immune status; diagnostic activators in the nature of proteins for use in diagnostic kits for disease diagnosis, screening, monitoring, prognosis, and immune status; diagnostic preparations for medical diagnostic use; diagnostic reagents for medical diagnostic use
Owner
- NKMAX CO., LTD., SEONGNAM-SI, GYEONGGI-DO, KR
- ATGen Co., Ltd., Gyeonggi-do 463-400, KR
- ATGen Co., Ltd., Gyeonggi-do 463-400, KR
- ATGen Co., Ltd., Gyeonggi-do 463-400, KR
Prosecution history
- 29 Dec 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 29 Dec 2025 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 29 Dec 2025 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 29 Dec 2025 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 29 Dec 2025 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 05 Jul 2025 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
- 04 Feb 2023 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 04 Feb 2023 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 04 Feb 2023 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 03 Aug 2022 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 19 Jul 2022 — TEAS SECTION 8 & 15 RECEIVED
- 05 Jul 2021 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 02 Dec 2016 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 05 Jul 2016 — REGISTERED-PRINCIPAL REGISTER
- 02 Jun 2016 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED